Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms
Authors (first, second and last of 12)
Volume 7, issue 1, December 2014
95 articles in this issue
-
-
-
Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations
Authors (first, second and last of 11)
-
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
Authors
This is part of 1 collection:
-
Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms
Authors (first, second and last of 15)
-
Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma
Authors (first, second and last of 5)
-
Functions of lncRNA HOTAIR in lung cancer
Authors (first, second and last of 4)
This is part of 1 collection:
-
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts
Authors (first, second and last of 14)
-
c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors
Authors (first, second and last of 8)
-
Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
Authors (first, second and last of 8)
-
-
Nucleo-cytoplasmic transport as a therapeutic target of cancer
Authors (first, second and last of 6)
-
-
MicroRNA-binding site polymorphisms in hematological malignancies
Authors
This is part of 1 collection:
-
Constitutional and somatic deletions of the Williams-Beuren syndrome critical region in Non-Hodgkin Lymphoma
Authors (first, second and last of 12)
-
SWI/SNF proteins as targets in cancer therapy
Authors (first, second and last of 4)
This is part of 1 collection:
-
Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction- a novel mechanism for maintaining vascular function
Authors (first, second and last of 6)
-
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia
Authors (first, second and last of 12)
-
Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
Authors (first, second and last of 4)
-
CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia
Authors (first, second and last of 9)
-
Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma
Authors (first, second and last of 12)
-
Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation
Authors (first, second and last of 10)
-
Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
Authors (first, second and last of 14)
-
DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
Authors (first, second and last of 9)
-
-
Notch1-induced T cell leukemia can be potentiated by microenvironmental cues in the spleen
Authors (first, second and last of 11)
-
Strategies for modern biomarker and drug development in oncology
Authors
This is part of 1 collection:
-
CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia
Authors (first, second and last of 5)
-
8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia
Authors (first, second and last of 15)
-
-
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia
Authors (first, second and last of 14)
-
Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma
Authors (first, second and last of 5)
-
Highly efficient, In-vivo Fas-mediated Apoptosis of B-cell Lymphoma by Hexameric CTLA4-FasL
Authors (first, second and last of 11)
-
Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression
Authors (first, second and last of 12)
-
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair
Authors (first, second and last of 15)
This is part of 1 collection:
-
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
Authors (first, second and last of 5)
-
Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)
Authors (first, second and last of 12)
-
New antibody approaches to lymphoma therapy
Authors (first, second and last of 4)
This is part of 1 collection:
-
Toll-like receptors in the pathogenesis of human B cell malignancies
Authors (first, second and last of 5)
-
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytes
Authors (first, second and last of 7)
-
Long-term follow-up of cytogenetically normal CEBPA-mutated AML
Authors (first, second and last of 13)
-
-
CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
Authors (first, second and last of 9)
-
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
Authors (first, second and last of 8)
-
Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients
Authors (first, second and last of 13)
-
Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells
Authors (first, second and last of 4)
-
IMP3 signatures of fallopian tube: a risk for pelvic serous cancers
Authors (first, second and last of 8)
-
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
Authors (first, second and last of 11)
-
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins
Authors (first, second and last of 10)
-
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
Authors (first, second and last of 12)
